Contributo dei Ricercatori del Centro a Meeting e Convegni - Archivio Storico

2009

Registro internazionale delle forme ricorrenti e familiari di SEU e PTT. (Erica Daina)
12° Convegno "Patologia Immune e Malattie Orfane"
Torino, 22-24 gennaio 2009

Regression of Chronic Renal Disease and the case of kidney self repairing; Thrombotic Microangiopathy. (Giuseppe Remuzzi)
Visiting Professor of the Moscow City Nephrology Center
Mosca (Russia), 30 gennaio 2009

XV Convention Scientifica Telethon
Riva del Garda (Trento), 9-11 marzo 2009

Registro internazionale delle forme ricorrenti e familiari di Sindrome Emolitico Uremica e Porpora Trombotica Trombocitopenica. (Erica Daina)
Malattie Rare: un'emergenza che emerge poco
Mogliano Veneto (Treviso), 18 aprile 2009

HUS and TTP: still two different diseases? (Giuseppe Remuzzi)
Int. Conference Current diagnosis and therapy of HUS, Keynore lecture
Innsbruck (Austria), 18 maggio 2009

Complement (C) activation contributes to microvascular thrombosis in shiga toxin-assiciated HUS. (Miriam Galbusera, Marina Noris, Giuseppe Remuzzi)
12th European meeting on complement in human disease
Visegrad (Ungheria), 5-8 settembre 2009

2° Congresso Nazionale Congiunto "Microangiopatie Trombotiche primitive. Genetica molecolare delle SEU atipiche e MTP"
Genova, 16-19 settembre 2009

HUS and TTP still two different diseases? (Giuseppe Remuzzi)
Renal Week, ASN 2009
San Diego (Stati Uniti), 29 ottobre 2009

La syndrome uremico-emolitica. (Miriam Galbusera)
XII Corso Educazionale SISET: Microangiopatie trombotiche e coagulopatie da consumo
Bosco Marengo (AL), 6-7 novembre 2009

2008

L'esempio delle microangiopatie trombotiche. (Giseuppe Remuzzi)
La Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena incontra il Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Dacco'
Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò – Istituto Mario Negri
Ranica (Bergamo), 24 gennaio 2008

Registro Internazionale delle forme ricorrenti e familiari di SEU e PTT (Erica Daina)
11° Convegno "Patologia Immune e Malattie Orfane"
Torino, 24-26 gennaio 2008

Polycystic Kidney Disease: Novel Treatment for Hypertension and changing the Course of the Disease;
Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome: Are they separate diseases?;
A novel look to Membranous Nephropathy;
Regression of Chronic Renal Disease and the case of kidney self repairing. (Giuseppe Remuzzi)
Distinguished Visiting Professor Beth Israel Deaconess Medical Center and Harvard Medical College, Boston
Boston (Stati Uniti), 12 marzo 2008

ADAMTS13 and complement interplay in the pathogenesis of thrombotic microangiopathis. (Miriam Galbusera)
6th Bari International Conference (BIC)
Vieste del Gargano (FG), 18-20 maggio 2008

XXII International Complement Workshop
Basilea, 28 settembre – 2 ottobre 2008

Genetic abnormalities of complement molecole in hemolytic uremic syndrome. (Elena Bresin, Marina Noris)
Phenotype correction of ADAMTS 13 deficiency and protection from the development of thrombotic thrombocytopenic purpura through intravascular and skeletal muscle ADAMTS 13 gene delivery in mice. (Giuseppe Remuzzi)
Congresso Internazionale Rare Diseases and Orphan Drugs.
Roma, 27-31 ottobre 2008

Role of complement in atypical HUS; Remission clinics-assessing risk benefits of treatment; Regression of CRD and the case of self repairing. (Giuseppe Remuzzi)
Annual Congress of American Society of Nephrology.
Philadelphia (Stati Uniti), 6 novembre 2008

Epidemiology of CKD: current world situation and clinical implications;
Pharmacological intervention in CKD: current results and progress. Is remission feasible;
Clinicopathological conference: HUS. (Giuseppe Remuzzi)
Int. symposium on chronic kidney disease: epidemiology, detection, prevention and intervention Cordoba (Argentina) 2008

2007

Renal disease progression: inexorable? But the kidney has the capacity to self-repair; Hemolytic Uremic Syndrome: advance of the last few years. (Giuseppe Remuzzi)
C. Craig Tisher Visiting Professor, University of Florida. Lezioni
Jacksonville e Gainesville, Florida (USA) 2007

11th European Meeting Complement in Human Disease
Cardiff UK, 8-11 settembre 2007

TTP and HUS: are they separate diseases? (Giuseppe Remuzzi)
Rituximab as effective treatment in refractory-recurrent TTP. (Miriam Galbusera)
3rd International Workshop on Thrombotic Microangiopathies
Jena, 4-6 ottobre 2007

HUS and Thrombotic Microangiopathies. (Giuseppe Remuzzi)
Mayo Clinic Workshop during the ASN
San Francisco (Stati Uniti), 2 novembre 2007

An International Network for Recurrent and Familial Forms of Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura
European Conference on Rare Diseases
Lisbona, 27-28 novembre 2007

2006

HUS Focusing on post transplant recurrence. (Giuseppe Remuzzi)
Visiting Professor Johns Hopkins University
Baltimora (Stati Uniti), 2 febbraio 2006

European Human Genetics Conference 2006
Amsterdam, 6-9 maggio 2006

Meccanismi patogenetici della microangiopatia trombotica. (Miriam Galbusera)
IV Incontro Nefrologico a Viterbo: Coagulazione e nefropatie
Viterbo, 23 giugno 2006

Reversal of chronic kidney disease; HUS; Transplantation achievements and open questions. (Giuseppe Remuzzi)
13th Budapest Nephrology School
Budapest (Ungheria), 25 agosto 2006

Overview HUS and TTP. (Giuseppe Remuzzi)
San Camillo Ospedale
Roma, 26 ottobre 2006

2005

Telethon Convention 2005
Salsomaggiore Terme, 6-8 Marzo 2005

Hemolytic Uremic Syndrome; Activities of COMGAN Research Committee in Emerging Countries; The future of renoprotection. (Giuseppe Remuzzi)
ISN COMGAN Course
Varadero (Cuba), 12 maggio 2005

Thrombotic microangiopathies and ADAMTS13: the Bergamo experience. (Miriam Galbusera)
5th Bari International Conference (BIC) on Hemopilia and Allied Disorders, von Willebrand factor (including ADAMTS-13) and Platelet Glycoproteins
Vieste del Gargano (FG), 22-25 maggio 2005

TTP Then and now. (Giuseppe Remuzzi)
International Workshop on Thrombotic Microangiopathies
Jena (Germania), 27 maggio 2005

10th European Meeting on Complement in Human Disease
Heidelberg, 9-13 Settembre 2005

Hemolytic Uremic Syndrome. (Giuseppe Remuzzi)
Long Island Regional Nephrology Conference
New York, Stati Uniti 2005

2004

Genetics of HUS (Giuseppe Remuzzi)
Vanderbilt Univeristy Visiting Professor
Nashville (USA), 15 aprile 2004

Hemolytic Uremic Syndrome. (Giuseppe Remuzzi)
3rd Course on Genetics and Renal Diseases
Genova, 4 giugno 2004

The novel road to thrombotic microangiopathies and how to interfere with their progression. (Giuseppe Remuzzi)
3rd Annual Conference: Prevention in Renal Disease
Toronto (Canada), 2 ottobre 2004

2003

IXth European Meeting on Complement in Human Diseases
"Association between mutations and polymorphisms of factor H gene and Hemolytic Uremic Syndrome"
Trieste, 6-9 Settembre 2003

VWF and VWF cleaving protease in the pathogenesis of TTP and HUS. (Miriam Galbusera)
XVII Meeting of the International Society of Haematology, European & African Division
Graz (Austria), 7-10 settembre 2003

12th Telethon Scientific Convention
"Complement genetic alterations in Hemolytic Uremic Syndromes"
Riva del Garda, 23-25 Novembre 2003

VWF and VWF cleaving protease in the pathogenesis of TTP and HUS. (Miriam Galbusera)
The 26th Congress of th Japanese Society on Thrombosis and Hemostasis
Tokyo (Giappone), 27-29 novembre 2003

2002

Sindrome Emolitico Uremica: dallo studio di casi rari si possono capire le cause di certe epidemie? (Giuseppe Remuzzi)
Lezione Corso Infermieri, Villa Camozzi
Ranica (BG), Italia

Remission, Regression of Chronic Renal Disease: a realistic Task for the new Generation Nephrologists; Hemolytic Uremic Syndrome. (Giuseppe Remuzzi)
Medical Grand Round, Northwestern University
Chicago (Stati Uniti)

HUS (Giuseppe Remuzzi)
International symposium of the Instituto Reina Sofia de Investigacion Nefrologica
Madrid (Spagna)

HUS: from the bug to the gene; Progression, remission and Regression of Chronic Renal Disease. (Giuseppe Remuzzi)
Sheffield Kidney Institute
Sheffield (U.K.)

2001

Remission/regression of chronic renal disease: A realistic task fort the new generation nephrologist;
Towards tolerance induction in transplantation: where are we now?
HUS-an overview.
Visiting Professor Guy's Hospital
Londra, Inghilterra

PTT
38° Congresso Nazionale della Società di Ematologia
Firenze, Italia

2000

Haemolytic uraemic syndrome.
Kongress fur nephrologie
Vienna, Austria

Current Knowledge on HUS.
XXVII° Congress new advances in the pathophysiology of Haemolitic Uremic Syndrome (HUS) and Thrombocytopenic Purpura
Nizza, Francia

Case presentations: Clinical Nephrology;
Guest lecture: The hemolytic uremic syndrome;
Mini -workshop: Renal vascular disease (Introduction).
The 4th workshop on Clinical Nephrology and progression of renal disease, Ismailia, Egitto

Sindrome emolitico uremica: dalla ricerca su casi rari si possono capire le cause di certe epidemie?
Corso per Infermieri Professionali di Ricerca Clinica
Ranica, Bergamo, Italia

1998

La sindrome Emolitico Uremica.
Università degli Studi di Perugia
Perugia, Italia

Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura.
15 th Conrad Pirani Annual Lectureship in Renal Pathology
New York, Stati Uniti

Progression of Renal Failure - pathomechnisms;
Hemolytic Uremic Syndrome.
Summer School Meeting
Izmir, Turchia

Pathogenesis of Hemolytic Uremic Syndrome.
XVth International Congress of Nephrology
Buenos Aires, Argentina

Sindrome Emolitico Uremica: prognosi subito favorevole e dopo?
Congresso Nazionale Ass. Microbiologi Clinici Italiani
Stresa, Italia

1997

La sindrome Emolitica Uremica
Università di Verona
Verona, Italia

HUS
International Congress of Nephrology: The Clinical Spectrum of ARF in the Pacific Rim, Viral and Bacterial ARF
Sydney, Australia

Understanding the nature of renal disease progression;
Gene Therapy: How soon for renal diseases;
Innovative antirejection therapies and tolerance induction;
HUS.
Annual Meeting Chilean Society of Nephrology
Santiago, Cile

The Pathogenesis and treatment of HUS.
American Society of Nephrology, Co-Chair of Clinical ScienceSymposium
San Antonio, Stati Uniti

Developments of HUS during the past 1-2 years.
HUS-Synsorb Trial Investigators
San Antonio, Stati Uniti

1996

Micro-angiopatie Trombotiche.
Giornate Nefrologiche Romane, 1996
Roma, Italia

Glomerular protein traffic; Pathogenesis and Management of TTP.
North American Pediatric Renal Transplant Cooperative Study, 6th Annual Workshop
Washington, Stati Uniti

Hemolytic Uremic Syndrome revisited.
Toronto University
Toronto, Canada

La Microangiopatia Trombotica: dal conteggio delle piastrine alla verotossina.
XIV Congresso Nazionale Società Italiana Studio Emostasi e Trombosi
Bergamo, Italia

The role of Nitric Oxide in Uremic Syndrome;
Hemolytic Uremic Syndrome Revisited.
XXIV Annual Winter Nephrology Symposium
Verona, Italia

HUS;
The endothelium asa target in Hemolytic Uremic Syndrome;
HUS and TTP, a spectrum of the same syndrome or two different disease entities;
Bilateral nephrectomy to cure severe cases of HUS.
Simposio Internacional en Homenaje al Dr. Carlos Gianantonio
Buenos Aires, Argentina

Lezione su: "Treatment of HUS and TTP".
Royal Society of Medicine, Section of Nephrology
Londra, Gran Bretagna

1995

Hemolytic Uremic Syndrome Revisited;
Mechanisms and mediators of donor-specific tolerance triggered by MHC allopeptides.
Penn Center for Molecular Studies of Kidney Diseases
Philadelphia, Stati Uniti

Aggiornamenti sulla sindrome emolitica uremica.
XIV Corso di perfezionamento in coagulazione Emostasi e Trombosi.
Bari, Italia